Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global circulating tumor cells isolation and detection market was valued at USD 7.98 billion in 2023. It is expected to grow at a CAGR of 11.2% during the forecast period of 2024-2032 and attain a market value of USD 20.75 billion by 2032. The market growth is driven by the increasing incidence of cancer across the globe. Patents are focused on advanced technologies such as CTC detection and enrichment methods and CTC direct detection methods.
The Global Circulating Tumor Cells Isolation and Detection Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for circulating tumor cell isolation and detection include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with circulating tumor cell isolation and detection. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within circulating tumor cell isolation and detection technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for circulating tumor cells isolation and detection technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with circulating tumor cell isolation and detection.
Analysis of Patent Applications
A comprehensive summary of several patent applications which were filed across different jurisdictions for circulating tumor cell isolation and detection, and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Analysis of Granted Patents
Detailed analysis of the granted patents across different jurisdictions for circulating tumor cells isolation and detection and their relative value in the IP is covered in the final report.
Isolating and detecting circulating tumor cells (CTCs) involves taking cancer cells out of the bloodstream and identifying them for prognostic or diagnostic purposes. By examining the existence and traits of these cells, this procedure makes it possible to evaluate the course of cancer and the effectiveness of treatment. Specialized blood collection techniques, cell separation technologies, and molecular assays for precise detection are common techniques.
The components of circulating tumor cell isolation and detection include kits and reagents, blood collection tubes, and devices/systems. These usually consist of detection systems, magnetic beads, and antibodies that raise the sensitivity and precision of CTC analysis.
Technological Advancement is Expected to Boost the Patent Industry Growth
Improving the detection technique’s sensitivity, accuracy, and efficiency advances in imaging technologies, molecular assays, and microfluidics allow for more accurate and dependable CTC analysis. This has helped in better cancer diagnosis and tracking. For instance, to improve the detection of CTCs and cell-free DNA, F. Hoffmann-La Roche introduced the "Roche ctDNA Liquid Biopsy" platform, which combines cutting-edge microfluidics and genomic analysis. With the help of this platform, non-invasive cancer monitoring has advanced significantly, making it possible to identify tumor cells in the bloodstream with greater accuracy and early detection. Patents covering these technologies are crucial for companies and thus impact the circulating tumor cells isolation and detection patent landscape significantly. For instance, there were 1,804 patents granted in 2022 which increased to 1,822 patents by 2023.
Growing Focus on Personalized Medicine is Expected to Propel Circulating Tumor Cells Isolation and Detection Patent Industry
The need for customized cancer treatments based on unique tumor profiles is driving the global market for circulating tumor cell (CTCs) isolation and detection. This is due to the increased emphasis on personalized medicine. Precise CTC analysis allows therapeutic approaches to be customized, improving patient outcomes and treatment efficacy.
The report will cover the following sections in detail:
Analysis by Product
Analysis by Technology
The breakup based on product includes kits and reagents, blood collection tubes, and devices/systems. Circulating tumor cells (CTCs) are stabilized and preserved for precise isolation and detection using blood collection tubes supplemented with specific additives. Anticoagulants and stabilizers are frequently included in these tubes to preserve the viability of CTCs for subsequent analysis.
Detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for circulating tumor cells isolation and detection patents, having around 67,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with circulating tumor cells isolation and detection patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the circulating tumor cells isolation and detection field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Genentech Inc
It is a prominent biotechnology company with its headquarters located in South San Francisco. The company was founded in 1976. Through advancements in circulating tumor cell (CTC) isolation and detection technologies, the company is contributing to the advancement of cancer diagnostics and treatments. Genentech's research in this area contributes to improved knowledge and treatment of cancer by using state-of-the-art scientific methodologies.
F. Hoffmann La Roche
Established in 1896, F. Hoffmann-La Roche is a leading global leader in pharmaceuticals and diagnostics, with its headquarters located in Basel, Switzerland. Through advancements in the isolation and detection of circulating tumor cells (CTCs), the company aims to improve cancer care by facilitating more accurate cancer diagnosis and individualized treatment plans. Roche's extensive experience facilitates innovative approaches in oncology research and clinical applications.
Other companies include Epic Sciences Inc., Human Genome Sciences Inc, Zymogenetics Inc, Ventana Med Syst Inc. (Roche Group), Massachusetts Inst Technology, Amgen Inc, Novartis AG, Curis Inc., Bristol Myers Squibb Co, Dana Farber Cancer Inst Inc, Inst Nat Sante Rech Med, US Health, among others.
The circulating tumor cells isolation and detection patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
Scope of the Report | Details |
Analysis by Product |
|
Analysis by Technology |
|
Analysis by Application |
|
Key Players Mentioned |
|
Geographies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124